AI處方合規性自動審核工具

首頁

AI 提示詞列表

醫療健康

處方審核助手

${:__('collect %s',處方審核助手)}$

醫療健康

利用AI輔助藥師快速識別處方中的藥物相互作用、劑量異常及禁忌症，提升用藥安全與審核效率。

提示內容

複製

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and Ibuprofen 400mg three times daily for joint pain. Please analyze if there are potential drug-disease interactions, drug-drug interactions, or inappropriate dosing risks in this prescription, particularly regarding the use of NSAIDs in patients with renal insufficiency, and provide adjustment suggestions or warnings to ensure medication safety.

複製

請作為資深臨床藥師，對以下患者處方進行合規性審查：患者為65歲男性，診斷為高血壓2級和輕度腎功能不全（eGFR 45ml/min），當前處方包含氨氯地平5mg每日一次、氫氯噻嗪25mg每日一次以及布洛芬400mg每日三次用於關節痛。請分析該處方中是否存在潛在的藥物-疾病相互作用、藥物-藥物相互作用或劑量不當風險，特別是針對腎功能不全患者的非甾體抗炎藥使用限制，並給出調整建議或警示說明，確保用藥安全。

複製

分享點擊複製鏈接

評論 (0)

0/300

提交

推薦

處方審核助手

Act as a senior clinical pharmacist. Review the provided patient electronic health record, including medical history, allergies, current medication list, and lab results, to audit the proposed prescription. Focus on analyzing drug-drug interaction risks, checking if dosages exceed renal adjustment limits, and identifying absolute contraindications. Finally, output a standardized audit report containing risk assessment levels and specific adjustment recommendations to ensure medication safety.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract patient demographics, diagnosis, and the list of prescribed medications. Then, based on the latest clinical practice guidelines and package inserts, evaluate the rationality of dosage, route of administration, and duration for each drug. Focus on identifying potential drug-drug interactions, drug-disease contraindications, or risks for special populations (e.g., hepatic or renal impairment). If potential issues are found, clearly specify the risk type and provide evidence-based alternative solutions or adjustment recommendations. Finally, output a structured, professional audit report to ensure patient safety and therapeutic efficacy.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Consider the patient's age, liver/kidney function, and allergy history to highlight potential risks and provide adjustment suggestions, ensuring the treatment plan aligns with the latest clinical guidelines.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's age, renal/hepatic function, and allergy history. Second, check for drug interactions, contraindications, or off-label usage risks based on current clinical guidelines. Finally, if potential risks are identified, clearly specify the risk type and provide specific adjustment suggestions or alternative solutions, ensuring the output is concise, professional, and adheres to medical safety standards.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.

處方審核助手

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.